Melody Agbuya-Flores, OD
Optometry · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Agbuya-Flores’s office at (408) 851-1000 to ask if they take your plan before you enroll.
Medicaid work
$1,894 in 2024
Medicaid paid $1,894 for 83 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $1,076 |
| DETERMINATION REFRACTIVE STATE | 71 | $818 |
| 2024 | 83 | 2 | 26 | $1,894 |
| 2023 | 236 | 3 | 28 | $0 |
| 2022 | 119 | 3 | 27 | $0 |
See the largest Medicaid services in earlier years
2023
| INTRM OPH EXAM NEW PATIENT | 13 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 34 | $0 |
| DETERMINATION REFRACTIVE STATE | 189 | $0 |
2022
| INTRM OPH EXAM NEW PATIENT | 14 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $0 |
| DETERMINATION REFRACTIVE STATE | 93 | $0 |
Drugs they prescribed that Part D paid
$9,257
Pharmacies billed $9,257 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 161) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
96 generic and 65 brand-name prescriptions · $9,257 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluorometholone | 29 | $4,348 | $150 |
| Cyclosporine | 23 | $2,105 | $92 |
| Erythromycin | 21 | $293 | $14 |
| Latanoprost | 18 | $291 | $16 |
| Ciprofloxacin | 20 | $272 | $14 |
See all 7 drugs
| Fluorometholone | 29 | $4,348 | $150 |
| Cyclosporine | 23 | $2,105 | $92 |
| Erythromycin | 21 | $293 | $14 |
| Latanoprost | 18 | $291 | $16 |
| Ciprofloxacin | 20 | $272 | $14 |
| Neomycin-Polymyxin-Dexameth | 15 | $203 | $14 |
| Brimonidine | 12 | $173 | $14 |
Year by year
| 2024 | 161 | 117 | 0% (0) | 40% | $9,257 |
| 2023 | 110 | 80 | 0% (0) | 53% | $7,592 |
| 2022 | 40 | 31 | 0% (0) | 57% | $4,207 |
| 2018 | 11 | None | 0% (0) | None | $5,060 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Fluorometholone | 22 | $3,478 | $158 |
| Ciprofloxacin | 24 | $314 | $13 |
| Neomycin-Polymyxin-Dexameth | 13 | $177 | $14 |
2022: 1 drug
| Fluorometholone | 11 | $1,787 | $162 |
Money from drug and device companies
$41 in 2022
| 2022 | 2 | 2 | None | $41 |
| 2021 | 2 | 3 | None | $134 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 3 | 4 | None | $72 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Kala Pharmaceuticals | Inveltys | $21 | 1 payment
|
| BioTissue Holdings | Prokera | $20 | 1 payment
|
See all 2 published payments
| BioTissue Holdings | Meals · 2022-05-16 | Prokera | $20 |
| Kala Pharmaceuticals | Meals · 2022-01-25 | Inveltys | $21 |
See earlier years (2021, 2020, 2019)
2021: $134
| Aerie Pharmaceuticals | Rhopressa | $99 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $36 | 2 payments
|
2020: $21
| Aerie Pharmaceuticals | Rhopressa | $21 | 1 payment
|
2019: $72
| Novartis Pharmaceuticals | Travatan Z | $31 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $21 | 1 payment
|
| Shire North American Group | Xiidra | $20 | 1 payment
|
Professional record
- NPI
- 1780946012
- Licence
- CA 14419TLG
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 1665 Dominican Way, Suite 122, Santa Cruz, CA, 95065
- NPI first listed
- 2012-06-12
- NPI last updated
- 2022-05-26
- NPI record certified
- 2022-05-26
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.